About SpeedySwab™
by

“Watmind USA is dedicated to bringing medically advanced solutions to market that address current and future healthcare needs. Our mission is to support the greater good by providing the necessary tools to help address health issues that impact our society.”

- Dan Davis, CEO, Watmind USA

is committed to providing solutions to support the government’s National COVID-19 Preparedness Plan by expanding the options, access and availability of self-tests. These over-the-counter tests will be a preventative step of the highly transferable COVID-19 virus.

The company’s flexible state-of-the-art production capabilities, logistics, and transportation services are designed to meet customer needs.

Key Features Include:

Logistical capabilities with a production and demand planning processes where order fill rates are optimized using collaborative forecasting and planning.

A distribution network process that can ship orders within 24 hours with the added capability to expedite order processing and transportation services for urgent orders. A highly automated, ISO 13485 certified manufacturing facility capable of producing millions of units per day by its highly trained team.

The SpeedySwab™ over-the-counter test was developed and brought to market by an experienced team of researchers, developers, scientists, and business professionals.

SpeedySwab™ underwent rigorous testing as part of the highly selective National Institutes of Health (NIH) Rapid Acceleration Diagnostics (RADx) Independent Test Assessment Program (ITAP), designed to bring innovative solutions to market to address COVID-19.

“The ability to collaborate with the RADx team, the scientific proficiency of its partners combined with the product’s proprietary technology ensures SpeedySwab’s viability as a competitive over-the-counter antigen test.”